Signaturefd, LLC Fulgent Genetics, Inc. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 2,224 shares of FLGT stock, worth $40,966. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,224

Previous 2,225 0.04%

Holding current value

$40,966

Previous $43,000 11.63%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$19.6 - $25.06 $19 - $25	-1 Reduced 0.04%	2,224 $48,000
Q2 2024 Jul 29, 2024	BUY	$19.09 - $22.57 $21,609 - $25,549	1,132 Added 103.57%	2,225 $43,000
Q1 2024 May 03, 2024	BUY	$21.55 - $29.29 $3,318 - $4,510	154 Added 16.4%	1,093 $23,000
Q4 2023 Jan 31, 2024	BUY	$23.64 - $30.27 $1,442 - $1,846	61 Added 6.95%	939 $27,000
Q3 2023 Nov 03, 2023	SELL	$26.74 - $40.81 $748 - $1,142	-28 Reduced 3.09%	878 $23,000
Q2 2023 Aug 01, 2023	SELL	$28.52 - $40.7 $10,039 - $14,326	-352 Reduced 27.98%	906 $33,000
Q1 2023 Apr 28, 2023	BUY	$29.39 - $36.27 $18,368 - $22,668	625 Added 98.74%	1,258 $39,000
Q4 2022 Jan 27, 2023	BUY	$29.23 - $40.28 $15,696 - $21,630	537 Added 559.38%	633 $18,000
Q3 2022 Nov 08, 2022	BUY	$37.92 - $63.74 $3,640 - $6,119	96 New	96 $4,000
Q2 2022 Aug 10, 2022	SELL	$47.98 - $62.75 $479 - $627	-10 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$49.85 - $96.11 $498 - $961	10 New	10 $1,000
Q4 2021 Jan 25, 2022	SELL	$77.3 - $105.0 $1,623 - $2,205	-21 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$74.87 - $110.87 $973 - $1,441	13 Added 162.5%	21 $2,000
Q2 2021 Jul 26, 2021	BUY	$66.8 - $100.45 $534 - $803	8 New	8 $1,000
Q1 2021 Apr 30, 2021	SELL	$59.3 - $183.85 $1,482 - $4,596	-25 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$31.01 - $52.1 $775 - $1,302	25 New	25 $1,000

Others Institutions Holding FLGT

# of Institutions

200

Shares Held

16M

Call Options Held

2.04M

Put Options Held

14K

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $557M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account